ATE152711T1 - Substituierte chinolincarboxylsäure - Google Patents

Substituierte chinolincarboxylsäure

Info

Publication number
ATE152711T1
ATE152711T1 AT90100839T AT90100839T ATE152711T1 AT E152711 T1 ATE152711 T1 AT E152711T1 AT 90100839 T AT90100839 T AT 90100839T AT 90100839 T AT90100839 T AT 90100839T AT E152711 T1 ATE152711 T1 AT E152711T1
Authority
AT
Austria
Prior art keywords
carboxylic acid
substituted quinolin
disclosed
quinolin carboxylic
substituted
Prior art date
Application number
AT90100839T
Other languages
English (en)
Inventor
John Frank Poletto
Dennis William Powell
Diane Harris Boschelli
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE152711T1 publication Critical patent/ATE152711T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
AT90100839T 1989-01-17 1990-01-16 Substituierte chinolincarboxylsäure ATE152711T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/298,585 US4968702A (en) 1989-01-17 1989-01-17 Substituted quinolinecarboxylic acids

Publications (1)

Publication Number Publication Date
ATE152711T1 true ATE152711T1 (de) 1997-05-15

Family

ID=23151154

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90100839T ATE152711T1 (de) 1989-01-17 1990-01-16 Substituierte chinolincarboxylsäure

Country Status (17)

Country Link
US (1) US4968702A (de)
EP (1) EP0379145B1 (de)
JP (1) JP3004025B2 (de)
KR (1) KR0140076B1 (de)
AT (1) ATE152711T1 (de)
AU (1) AU624471B2 (de)
CA (1) CA2007740C (de)
DE (1) DE69030632T2 (de)
DK (1) DK0379145T3 (de)
ES (1) ES2100851T3 (de)
GR (1) GR3023585T3 (de)
HK (1) HK1008019A1 (de)
IE (1) IE900169L (de)
IL (1) IL92898A (de)
NZ (1) NZ232111A (de)
PH (1) PH26961A (de)
ZA (1) ZA90299B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310732A (en) * 1986-02-03 1994-05-10 The Scripps Research Institute 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis
TW232013B (de) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
US5409886A (en) * 1993-02-18 1995-04-25 Mitsui Toatsu Chemicals, Incorporated 3-pyrroline-2-one derivatives and herbicidal compositions containing same
US5393891A (en) * 1993-06-08 1995-02-28 The Du Pont Merck Pharmaceutical Company Immunoassay reagents and methods for detecting brequinar and analogs
US5428040A (en) * 1993-08-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
US5453431A (en) * 1993-10-29 1995-09-26 Gilman; Andrew L. Use of hydroxychloroquine for treatment of graft-versus-host disease
US5578609A (en) * 1994-03-25 1996-11-26 The Dupont Merck Pharmaceutical Company 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6172084B1 (en) 1997-06-19 2001-01-09 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
WO1999038846A1 (en) * 1998-01-30 1999-08-05 Procept, Inc. Immunosuppressive agents
AR029489A1 (es) * 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
AR036873A1 (es) * 2001-09-07 2004-10-13 Euro Celtique Sa Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
AR037233A1 (es) 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
WO2004014377A1 (en) * 2002-08-13 2004-02-19 Warner-Lambert Company Llc 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors
US7138412B2 (en) 2003-03-11 2006-11-21 Bristol-Myers Squibb Company Tetrahydroquinoline derivatives useful as serine protease inhibitors
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
AU2014209107B2 (en) * 2013-01-28 2018-04-12 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
EP3071199A2 (de) 2013-11-22 2016-09-28 Genzyme Corporation Neuartiges verfahren zur behandlung neurodegenerativer erkrankungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE294159C (de) *
US2888346A (en) * 1955-08-22 1959-05-26 Gen Aniline & Film Corp Ultra-violet absorbing compounds
FR2166297A1 (en) * 1972-01-07 1973-08-17 Rosenberg Eli 2-(4-isopropylphenyl)quinoline-4-carboxylic acid - as a non-toxic, analgesic agent
DE3483704D1 (de) * 1983-07-22 1991-01-17 Du Pont Phenylchinolinsaeure und derivate als antitumormittel.
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
EP0318093A3 (de) * 1987-11-25 1990-12-05 Merck Frosst Canada Inc. Diarylchinolindicarbonsäure und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
NZ232111A (en) 1992-07-28
US4968702A (en) 1990-11-06
KR900011733A (ko) 1990-08-02
JP3004025B2 (ja) 2000-01-31
GR3023585T3 (en) 1997-08-29
EP0379145A3 (de) 1991-07-17
EP0379145A2 (de) 1990-07-25
AU624471B2 (en) 1992-06-11
IE900169L (en) 1990-07-17
IL92898A (en) 1994-11-28
PH26961A (en) 1992-12-28
ZA90299B (en) 1990-10-31
HK1008019A1 (en) 1999-04-30
KR0140076B1 (ko) 1998-06-01
CA2007740C (en) 1999-12-07
DE69030632D1 (de) 1997-06-12
EP0379145B1 (de) 1997-05-07
IL92898A0 (en) 1990-09-17
CA2007740A1 (en) 1990-07-17
ES2100851T3 (es) 1997-07-01
JPH02229166A (ja) 1990-09-11
DE69030632T2 (de) 1997-10-02
AU4850290A (en) 1990-07-26
DK0379145T3 (da) 1997-05-26

Similar Documents

Publication Publication Date Title
ATE152711T1 (de) Substituierte chinolincarboxylsäure
ES2058614T3 (es) 1,2-ciclohexilaminoarilaminadas utiles como agentes analgesicos.
EP0397697A4 (en) Quinoline derivatives as antagonists of leukotriene d 4?
FI884375A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(1-alkyyli-3-hydroksi-4-piperidinyyli)bentsamidien valmistamiseksi
AU6995391A (en) Intermediates in the preparation of novel bicyclic esters and amides useful as specific 5-ht3 antagonists
NO873125D0 (no) Fremgangsmaate for fremstilling av antibakterielle forbindelser.
FI892012A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4-fenyyli-piperidiiniyhdisteiden valmistamiseksi
FI883997A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi
NL980015I1 (nl) Nieuwe 2-c(2,6-dichloorfenyl)amine!fenylacetoxyacetylderivaten, werkwijze voor de bereiding ervan enhun therapeutisch gebruik.
FI881892A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 1,2,5,6-tetrahydropyridiinijohdannaisten valmistamiseksi
PL286043A1 (en) Method for manufacturing new proteins
FI883378A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(3-hydroksi-4-piperidinyyli)bentsamidien valmistamiseksi
ATE101147T1 (de) Pharmazeutisch verwendbare polymorphe modifikation von buspiron.
FI890503A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1-syklopropyyli-6-fluori-7-(3,3-disubstituoitu-1-pyrrolidinyyli)-1,4-dihydro-4-okso-3-kinoliinikarboksyylihappojen valmistamiseksi
NO176961C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-fenyl-5, 6-dihydrobenz[cÅakridin-7-karboksylsyrer og beslektede forbindelser
FI921717A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-metoksi-10-(1-hydroksietyyli)-11-okso-1-atsatrisyklo/7.2.0.03,8/-undek-2-eeni-2-karboksyylihappojen asyylioksialkyyliestereiden valmistamiseksi
BE885483A (fr) Procede de preparation d'anhydrides d'acides carboxyliques
FI940869A0 (fi) Menetelmä karboksyylihappoanhydridien valmistamiseksi
FI912363L (fi) Menetelmä terapeuttisesti käyttökelpoisten -oksopyrrolo/2,3-b/indolietikkahappoestereiden ja -amidien valmistamiseksi
FI922268L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten N-difenyylialkyylialkoksisubstituoitujen 3-piperidiinikarboksyylihappojohdannaisten valmistamiseksi
FR2623801B1 (fr) Procede de purification de l'hexamethylenediamine
NO900261D0 (no) Mellomprodukt og fremgangsmaate for fremstilling av isopropyl-3s-amino-2r-hydroksy-alkanoater.
ATE66453T1 (de) Herstellung von zwischenverbindungen fuer leukotrien-antagonisten.
FR2663630B1 (fr) Procede d'esterification des acides carboxyliques.
FI934054L (fi) Menetelmä antibakteeristen karboksyylihappojohdannaisten valmistuksessa käyttökelpoisten välituotteiden valmistamiseksi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee